Human Organoids Market Share

APAC Market Statistics

The Asia Pacific human organoids market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the rising need for organ transplantation and donation. It is projected that around 180,000 people experience renal failure every year, out of which only 6000 kidney transplants are carried out. Moreover, around 10-15% of the 200,000 individuals dies in India each year from liver cancer or failure. However, they could be spared with a prompt liver transplant. As a result, India needs between 25 and 30 thousand liver transplants each year. Furthermore, rising cases of infectious disease in the region is also expected to boost the market growth in Asia Pacific. More than 1 million cases of contagious diarrhea were reported in China in 2021.

North American Market Forecast   

The North American human organoids market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The market growth in the region is attributed to the high technological advancement in the field of transplantation, accompanied by the presence of well-established distribution channels for the supply of human organoid products in the region. Along with this, North America also leads in terms of government healthcare expenditure, which is also expected to contribute to the market growth in the region. According to the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America.